2007 prospects of Chinas Medicines and Health Products Market.docVIP

2007 prospects of Chinas Medicines and Health Products Market.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
2007 prospects of Chinas Medicines and Health Products Market

 PAGE \* MERGEFORMAT 5 2007 prospects of China’s Medicines and Health Products Market Chinese health products has always been a hero of the battlefield, from the sea of the late 90s and tactical marketing conference in 2000, in the 2005’s integrated marketing, has been an open market competition in the country, the health products industry has created one after another myth. In this heterogeneous market, product prices to consumers as well as national leaders have been concerned about the issue of a fight. But the medicines, health care products in such a competitive environment is always under such high prices, has been troubled by the state departments concerned, the price is always a slogan that any price reduction product must also be the products that will be lost, or has a price-free goods, at or hospitals, pharmacies unwilling to sell, to the release of the Treasury and the few people is interested. Traced the reason was that the profit of the problem. In 2007 will be the pharmaceutical sector, an industry standard years. 2006 as the government’s drug approval review of senior officials to fall one after another, and exposed a series of loopholes, the state will have to focus on the source of drug control, from the 2005 GSP compulsory certification, be said that China’s formal drug production manufacturers are product quality is generally not much problem. That is the homogenization of very serious, particularly in generic drugs, so in approval processing, the state will hire more professional talents of drugs to carry out drug production license approval to cancel the current examination and approval authority for more staff in the administrative body , as its administrative staff in itself is a layman, with the production process of this do not understand drugs, drug formulations, it is not possible to better monitor the production of drugs, and the future of many professional talents to join the Chinese health sector, the exercise of the right o

文档评论(0)

jiupshaieuk12 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:6212135231000003

1亿VIP精品文档

相关文档